Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Left Atrium Role in Secondary Mitral Regurgitation
Author(s): Markos Koukos , Yannis Dimitroglou , Dimitrios Tsartsalis , et al Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
30th Annual Meeting of the ISCP
Author(s): Maki Komiyama Added: 3 weeks ago

Prevention & Chronic Conditions

Heart Failure
Job title: Professor of Pathology and Medical and Research Technology
Arrhythmogenic Cardiomyopathy with Prof Elena Arbelo
Author(s): Elena Arbelo Added: 5 months ago
Understand the evolving landscape of arrhythmogenic cardiomyopathy (ACM) risk stratification and ICD decision-making with Prof Elena ArbeloThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical shift from phenotype-based to genotype-informed risk assessment in arrhythmogenic cardiomyopathy management, addressing the significant challenge that over half of… View more

Electrophysiology & Arrhythmia

Imaging & Diagnostics
Pablo Avanzas
Research Area(s) / Expertise: Job title: Consultant in Invasive Cardiology
Dr Avanzas graduated from Universidad de Navarra with full honours in 1998 and passed the Postgraduate Board in Cardiovascular Diseases at Gregorio Marañón Hospital in 2004. He took up a Spanish Heart Foundation Research Fellowship at Coronary Artery Research Unit, St. George´s Hospital Medical School in London and some months after that he was appointed as Associate Research Investigator of… View more
Job title: Director
CRT 25: Insights from the GUARD Study
Author(s): Baravan Al-Kassou Added: 1 year ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated… View more

Vascular Disease and Surgery
ERA 25: eGFR Dips and Disease Severity on Empagliflozin
Author(s): Added: 11 months ago
ERA 2025 - Results from a meta-analysis of trials including EMPA-KIDNEY show the treatment effect of empagliflozin is not modified by level of predicted acute eGFR dip.Dr Natalie Staplin (University of Oxford, Oxford, UK) joins us to discuss findings from a meta-analysis of four trials, including the EMPA-KIDNEY trial (NCT03594110), investigating the impact of acute eGFR dips and markers of… View more

Cardiovascular Kidney Metabolic
Nothing to REFINE Yet
Author(s): Gheorghe-Andrei Dan Added: 5 months ago

Guidelines & Statements

Heart Failure
Job title: Associate Director of Medical and Scientific Affairs